Cardiovascular

Cardiovascular CRO for Clinical Research

The Cardiovascular teams at Medpace are highly skilled in the scientific methodology, standard of care, evolving regulatory requirements and operational considerations that are necessary to bring drugs and devices that treat or prevent heart disease to market. Our extensive experience in cardiovascular studies paired with our proven track record of success in the cardiovascular CRO industry ensures the flexibility to adapt to the unique needs of each cardiovascular trial.

In order to ensure success, we help our clients:

• Effectively plan and conduct cardiovascular studies for drug/device and cardiac safety
• Efficiently conduct large cardiovascular endpoint trials that demand rigorous safety requirements
• Seamlessly integrate cardiovascular trials with metabolic/endocrinology projects

Deep and Broad Cardiovascular Experience

Since inception in 1992, we have conducted hundreds of Phase I-IV cardiovascular trials for drugs and medical devices.
Through these studies, we have:

• Involved patients in nearly 50 different countries
• Contributed to countless cardiovascular NDAs
• Pioneered many of the preventative cardiovascular drugs and devices introduced in the past 15 years
• Conducted studies including acute care setting, drug/device combination, large outcome, thorough QT, as well as managing Clinical Endpoint Committees (CEC) and adjudication processes for numerous studies